April 19, 2021 |
Brazilian private healthcare group Mater Dei saw its shares fall sharply after its debut on the B3 stock exchange in São Paulo on Friday, while pharmaceutical company Blau Farmacêutica came to market with a smaller offering and a reduced price due to limited demand from investors.
Mater Dei had raised BRL1.6 billion ($286 million) in an IPO on Wednesday, after lowering the price per share by 20% to BRL17.44, but its shares closed at BRL16.80 on Friday, down 3.67% on the day.
The company kept BRL
Brazilian healthcare group Mater Dei sees its shares fall after its market debut as pharmaceutical company Blau prices a reduced offering below target